UK’s drug-cost watchdog recommends use of GSK unit’s HIV prevention drug
(Reuters) -The UK’s drugs cost-effectiveness watchdog has given a positive recommendation for ViiV Healthcare’s HIV drug, enabling access to the preventive medicine via the state health system in England and Wales, the GSK unit said on Friday. The country’s drug regulator had approved ViiV’s injection, Apretude, last year for prevention of HIV-1 in adults and …
UK’s drug-cost watchdog recommends use of GSK unit’s HIV prevention drug Read More »








